FENC insider filings

FENNEC PHARMACEUTICALS INC. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-16. Screen FENC transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 24 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Andrade Robert — CHIEF FINANCIAL OFFICER5—1 leg · 75,000 sh · $883,5006
Brughera Marco Maria — Director2—2 legs · 35,545 sh · $399,9584
Sayad Pierre Sargis — Chief Medical Officer4—1 leg · 12,000 sh · $146,1604
Raykov Rosty1—1 leg · 10,000 sh · $121,1001
Cioffi Christiana Marie — Chief Strategy Officer4——4
Evans Terry L — Chief Commercial Officer4——4
Hackman Jeffrey S. — Chief Executive Officer, Director4——4

Recent insider filings — FENNEC PHARMACEUTICALS INC.

FiledFormInsiderReported transactionsSource
2026-11-164Brughera Marco Maria — DirectorOption exercise (M): 20,000 @ $2.11 · Sale (S): 20,000 @ $12 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2026-11-024Evans Terry L — Chief Commercial OfficerGrant/award (A): 168 @ $0EDGAR
2026-11-024Hackman Jeffrey S. — Chief Executive Officer, DirectorGrant/award (A): 1,159 @ $0EDGAR
2026-11-024Sayad Pierre Sargis — Chief Medical OfficerGrant/award (A): 168 @ $0EDGAR
2026-11-024Cioffi Christiana Marie — Chief Strategy OfficerGrant/award (A): 156 @ $0EDGAR
2026-11-024Andrade Robert — CHIEF FINANCIAL OFFICERGrant/award (A): 1,703 @ $0EDGAR
2026-10-134Andrade Robert — CHIEF FINANCIAL OFFICERGrant/award (A): 3,846 @ $5.53EDGAR
2026-10-134Cioffi Christiana Marie — Chief Strategy OfficerGrant/award (A): 3,946 @ $5.53EDGAR
2026-10-134Evans Terry L — Chief Commercial OfficerGrant/award (A): 2,326 @ $5.53EDGAR
2026-10-134Hackman Jeffrey S. — Chief Executive Officer, DirectorGrant/award (A): 2,224 @ $5.53EDGAR
2026-10-134Sayad Pierre Sargis — Chief Medical OfficerGrant/award (A): 3,846 @ $5.53EDGAR
2026-10-014Andrade Robert — CHIEF FINANCIAL OFFICERGrant/award (A): 1,703 @ $0EDGAR
2026-10-014Cioffi Christiana Marie — Chief Strategy OfficerGrant/award (A): 156 @ $0EDGAR
2026-10-014Hackman Jeffrey S. — Chief Executive Officer, DirectorGrant/award (A): 1,159 @ $0EDGAR
2026-10-014Evans Terry L — Chief Commercial OfficerGrant/award (A): 168 @ $0EDGAR
2026-10-014Sayad Pierre Sargis — Chief Medical OfficerGrant/award (A): 168 @ $0EDGAR
2026-09-164Brughera Marco Maria — DirectorOption exercise (M): 15,545 @ $2.11 · Sale (S): 15,545 @ $10.29 · Option exercise (M): 15,545 (derivative) @ $0EDGAR
2026-09-014Raykov RostyGrant/award (A): 2,778 @ $0 · Sale (S): 10,000 @ $12.11EDGAR
2026-08-314Cioffi Christiana Marie — Chief Strategy OfficerGrant/award (A): 156 @ $0EDGAR
2026-08-314Evans Terry L — Chief Commercial OfficerGrant/award (A): 168 @ $0EDGAR
2026-08-314Sayad Pierre Sargis — Chief Medical OfficerGrant/award (A): 168 @ $0 · Sale (S): 12,000 @ $12.18EDGAR
2026-08-314Hackman Jeffrey S. — Chief Executive Officer, DirectorGrant/award (A): 1,159 @ $0EDGAR
2026-08-314Andrade Robert — CHIEF FINANCIAL OFFICERGrant/award (A): 1,703 @ $0EDGAR
2026-08-284Andrade Robert — CHIEF FINANCIAL OFFICERSale (S): 75,000 @ $11.78 · Option exercise (M): 21,928 @ $5.10 · Option exercise (M): 21,928 (derivative) @ $0EDGAR
2026-08-044Raykov RostySale (S): 10,000 @ $9.58EDGAR
2026-08-034Andrade Robert — CHIEF FINANCIAL OFFICERGrant/award (A): 1,703 @ $0EDGAR
2026-08-034Raykov RostyGrant/award (A): 2,778 @ $0EDGAR
2026-08-034Hackman Jeffrey S. — Chief Executive Officer, DirectorGrant/award (A): 1,159 @ $0EDGAR
2026-08-034Cioffi Christiana Marie — Chief Strategy OfficerGrant/award (A): 156 @ $0EDGAR
2026-08-034Evans Terry L — Chief Commercial OfficerGrant/award (A): 168 @ $0EDGAR
2026-08-034Sayad Pierre Sargis — Chief Medical OfficerGrant/award (A): 168 @ $0EDGAR
2026-07-024Raykov RostyGrant/award (A): 2,778 @ $0 · Option exercise (M): 15,597 @ $2.45 · Sale (S): 9,599 @ $10.41 · Option exercise (M): 15,597 (derivative) @ $2.45EDGAR
2026-07-014Cioffi Christiana Marie — Chief Strategy OfficerGrant/award (A): 156 @ $0EDGAR
2026-07-014Sayad Pierre Sargis — Chief Medical OfficerGrant/award (A): 168 @ $0EDGAR
2026-07-014Evans Terry L — Chief Commercial OfficerGrant/award (A): 168 @ $0EDGAR
2026-07-014Hackman Jeffrey S. — Chief Executive Officer, DirectorGrant/award (A): 1,159 @ $0EDGAR
2026-07-014Andrade Robert — CHIEF FINANCIAL OFFICERGrant/award (A): 1,703 @ $0EDGAR
2026-06-104Cook Jodi A — DirectorGrant/award (A): 20,000 (derivative) @ $8.70EDGAR
2026-06-104Islam Khalid — DirectorGrant/award (A): 25,000 (derivative) @ $8.70EDGAR
2026-06-104Brughera Marco Maria — DirectorGrant/award (A): 20,000 (derivative) @ $8.70EDGAR
2026-06-104RALLIS CHRIS A — DirectorGrant/award (A): 20,000 (derivative) @ $8.70EDGAR
2026-06-024Raykov Rosty — DirectorGrant/award (A): 2,778 @ $0 · Option exercise (M): 15,597 @ $2.45 · Sale (S): 9,747 @ $9.62 · Option exercise (M): 15,597 (derivative) @ $2.45EDGAR
2026-06-014Cioffi Christiana Marie — Chief Strategy OfficerGrant/award (A): 156 @ $0EDGAR
2026-06-014Sayad Pierre Sargis — Chief Medical OfficerGrant/award (A): 168 @ $0EDGAR
2026-06-014Evans Terry L — Chief Commercial OfficerGrant/award (A): 168 @ $0EDGAR
2026-06-014Hackman Jeffrey S. — Chief Executive Officer, DirectorGrant/award (A): 1,159 @ $0EDGAR
2026-06-014Andrade Robert — CHIEF FINANCIAL OFFICERGrant/award (A): 1,703 @ $0EDGAR
2026-05-124RALLIS CHRIS A — DirectorOption exercise (M): 14,344 @ $2.44 · Sale (S): 8,346 @ $7.04 · Option exercise (M): 14,344 (derivative) @ $2.44EDGAR
2026-05-014Raykov Rosty — DirectorOption exercise (M): 2,778 @ $0 · Option exercise (M): 15,598 @ $2.45 · Sale (S): 10,781 @ $6.47 · Option exercise (M): 15,598 (derivative) @ $2.45EDGAR
2026-05-014Andrade Robert — CHIEF FINANCIAL OFFICEROption exercise (M): 1,703 @ $0EDGAR

Recent 8-K events — FENNEC PHARMACEUTICALS INC.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-09-178-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-108-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-228-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-188-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-288-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-04-228-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-078-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-248-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-168-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-048-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=FENC returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs